FDA Approved: LAMOTRIGINE — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for lamotrigine by Amneal Pharmaceuticals LLC (ANDA 207497).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Epilepsy

Drugs mentioned

• Lamotrigine (lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE (LAMOTRIGINE)